Let's Talk ID

Is air travel actually safe right now? Dr. Trish Perl of UT Southwestern Medical Center and Tori Barnes, Executive Vice President of Public Affairs and Policy with the U.S. Travel Association join us to address concerns and questions surrounding travel amid the COVID-19 pandemic.

Dr. Jonathan Iralu of Indian Health Service and Dr. Donald Warne, director of Indians into Medicine, of the University of North Dakota join us to discuss the disparities COVID-19 has brought to light within the Native American population.

From the importance of monitoring community spread to best practices for screening, Wendy Armstrong, M.D., FIDSA of Emory University, Tina Tan, M.D., FIDSA of Northwestern University & Noelle Ellerson Ng, Associate Executive Director, Advocacy and Governance of the Schools Superintendents Association, share how schools and parents should navigate reopening amid the COVID-19 pandemic.

Will re-opening plans be undone by off-campus social life? Preeti Malani, M.D., FIDSA of the University of Michigan and Carlos del Rio, M.D., FIDSA of Emory University discuss the obstacles colleges and universities will face amid the COVID-19 pandemic.

We discuss how health care organizations have been impacted financially by COVID-19, how they're responding and what the plans are for recovery with Russ Petrak, M.D., FIDSA of Metro ID Consultants, Steven Gordon, M.D., FIDSA of the Cleveland Clinic and William Schpero of Cornell Medical College.

*This podcast episode was funded by a cooperative agreement with the Centers for Disease Control and Prevention (grant number 6 NU50CK000477-04-01). The Centers for Disease Control and Prevention is an agency within the Department of Health and Human Services (HHS). The contents of this podcast do not necessarily represent the policy of CDC or HHS, and should not be considered an endorsement by the Federal Government.

Guest moderator Dr. Jasmine Marcelin is joined by Drs. Magdala Chery, Jacinda Abdul & Jessica Queen to discuss the systemic barriers that COVID-19 has brought to light & how health care providers can take action.

*This podcast episode was funded by a cooperative agreement with the Centers for Disease Control and Prevention (grant number 6 NU50CK000477-04-01). The Centers for Disease Control and Prevention is an agency within the Department of Health and Human Services (HHS). The contents of this podcast do not necessarily represent the policy of CDC or HHS, and should not be considered an endorsement by the Federal Government.

How quickly will a COVID-19 vaccine be available, and will it be safe and effective? Dr. Kathryn Edwards of Vanderbilt University and Dr. Walter Orenstein of Emory University join us to discuss the status of a COVID-19 vaccine and the steps necessary to distribute an effective one.

*This podcast episode was funded by a cooperative agreement with the Centers for Disease Control and Prevention (grant number 6 NU50CK000477-04-01). The Centers for Disease Control and Prevention is an agency within the Department of Health and Human Services (HHS). The contents of this podcast do not necessarily represent the policy of CDC or HHS, and should not be considered an endorsement by the Federal Government.

IDSA Global Health Committee Chair Dr. Judith Wasserheit of the University of Washington and Dr. Charles Holmes of Georgetown University join us to discuss the critical role of the World Health Organization in COVID-19 response efforts & how its defunding could impact our ability to prevent, detect & respond to future pandemics.

*This episode was recorded prior to the White House’s announcement on July 7th that the U.S. is officially terminating relations with the WHO.

We're joined by Drs. Liise-Anne Pirofski of Albert Einstein College of Medicine & Shmuel Shoham of Johns Hopkins University to examine convalescent plasma and its role in the treatment of COVID-19.

We’re joined by Drs. Adarsh Bhimraj of the Cleveland Clinic & Rajesh Gandhi of Massachusetts General Hospital to discuss all things remdesivir, including how the antiviral combats COVID-19, what will happen if supplies are depleted & the latest clinical trial information.